$0.00 EPS Expected for Educational Development (EDUC); Enanta Pharmaceuticals (ENTA) Shorts Raised By 10.7%

Enanta Pharmaceuticals Incorporated (NASDAQ:ENTA) had an increase of 10.7% in short interest. ENTA’s SI was 1.55 million shares in May as released by FINRA. Its up 10.7% from 1.40 million shares previously. With 211,900 avg volume, 7 days are for Enanta Pharmaceuticals Incorporated (NASDAQ:ENTA)’s short sellers to cover ENTA’s short positions. The SI to Enanta Pharmaceuticals Incorporated’s float is 11.72%. About 70,550 shares traded. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) has risen 20.00% since September 29, 2016 and is uptrending. It has outperformed by 8.46% the S&P500.

Analysts expect Educational Development Corporation (NASDAQ:EDUC) to report $0.00 EPS on May, 25. About 4,732 shares traded. Educational Development Corporation (NASDAQ:EDUC) has declined 18.55% since September 29, 2016 and is downtrending. It has underperformed by 30.09% the S&P500.

Investors sentiment increased to 0.43 in 2016 Q4. Its up 0.12, from 0.31 in 2016Q3. It improved, as 4 investors sold Educational Development Corporation shares while 3 reduced holdings. 1 funds opened positions while 2 raised stakes. 357,306 shares or 6.18% less from 380,861 shares in 2016Q3 were reported. Manufacturers Life Insurance Com The owns 0% invested in Educational Development Corporation (NASDAQ:EDUC) for 79 shares. Vanguard Inc owns 106,150 shares. California-based Blackrock Fund Advsr has invested 0% in Educational Development Corporation (NASDAQ:EDUC). Bridgeway Cap Mgmt Inc holds 0.01% in Educational Development Corporation (NASDAQ:EDUC) or 65,400 shares. Blackrock Investment Limited Liability Company has invested 0% in Educational Development Corporation (NASDAQ:EDUC). Renaissance Technology Ltd Co holds 0% or 19,731 shares in its portfolio. Geode Cap Mgmt Ltd Liability Company has invested 0% in Educational Development Corporation (NASDAQ:EDUC). Fifth Third Fincl Bank owns 37 shares. First Wilshire Mngmt reported 38,292 shares. Ancora Limited Liability Corp owns 0% invested in Educational Development Corporation (NASDAQ:EDUC) for 700 shares. Dimensional Fund Advsr Limited Partnership has 0% invested in Educational Development Corporation (NASDAQ:EDUC). Morgan Stanley has invested 0% of its portfolio in Educational Development Corporation (NASDAQ:EDUC).

Educational Development Corporation is a publisher of the line of educational children’s books produced in the United Kingdom by Usborne Publishing Limited (Usborne). The company has market cap of $37.16 million. The Firm also owns Kane Miller Book Publishers. It has a 17.07 P/E ratio. The Firm sells books through two divisions: Home Business Division (Usborne Books & More or UBAM) and Publishing Division (EDC Publishing).

Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The company has market cap of $586.29 million. The Firm uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for the treatment of viral infections and liver diseases. It currently has negative earnings. The Company’s research and development programs are focused on three disease targets: non-alcoholic steatohepatitis / primary biliary cholangitis (PBC), respiratory syncytial virus (RSV) and hepatitis B virus (HBV).

Investors sentiment decreased to 1.47 in Q4 2016. Its down 0.06, from 1.53 in 2016Q3. It dropped, as 13 investors sold Enanta Pharmaceuticals Inc shares while 36 reduced holdings. 23 funds opened positions while 49 raised stakes. 12.65 million shares or 0.84% less from 12.75 million shares in 2016Q3 were reported. Tower Capital Limited Liability Corp (Trc) owns 1,070 shares. 8,000 were accumulated by Art Advsr Lc. 23,524 are owned by Rhumbline Advisers. Blackrock Japan Limited accumulated 0% or 430 shares. Alliancebernstein L P holds 132,060 shares or 0% of its portfolio. Weiss Multi holds 0.03% of its portfolio in Enanta Pharmaceuticals Inc (NASDAQ:ENTA) for 20,000 shares. Qs Ltd Limited Liability Company holds 0.02% of its portfolio in Enanta Pharmaceuticals Inc (NASDAQ:ENTA) for 78,341 shares. Loomis Sayles And Communications Lp stated it has 0% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Aqr Capital Mngmt Ltd Company invested 0.01% of its portfolio in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Virginia Retirement Et Al owns 28,400 shares or 0.01% of their US portfolio. Spark Invest Mgmt, New York-based fund reported 190,800 shares. Nationwide Fund Advsr has invested 0% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). Oakworth Capital stated it has 263 shares. Public Sector Pension Invest Board, a Quebec – Canada-based fund reported 9,900 shares. Gsa Llp stated it has 0.15% in Enanta Pharmaceuticals Inc (NASDAQ:ENTA).